It has generally been accepted that the vagal effect participates in bradycardia due to cardiac glycosides (1, 2). However, the vagal effect may not be the only factor which produces the cardiac slowing, because cardiac glycosides can produce bradycardia even after bilateral severance of vagus nerves or under the effect of atropine (3, 4). Gold et al. (5, 6 ) suggested a direct bradycardiac action of cardiac glycosides on the heart muscle. However, the results on the effect of cardiac glycosides on the heart rate are still con troversial in the experiments with isolated hearts. Heymans et al. (7, 8) reported that cardiac glycosides did not produce bradycardia in dogs when vagus nerves and also carotid sinus nerves were completely severed. The present author has also obtained a similar finding in cats using a cardiac glycoside, strospeside (9).
It has generally been accepted that the vagal effect participates in bradycardia due to cardiac glycosides (1, 2) . However, the vagal effect may not be the only factor which produces the cardiac slowing, because cardiac glycosides can produce bradycardia even after bilateral severance of vagus nerves or under the effect of atropine (3, 4) . Gold et al. (5, 6 ) suggested a direct bradycardiac action of cardiac glycosides on the heart muscle. However, the results on the effect of cardiac glycosides on the heart rate are still con troversial in the experiments with isolated hearts. Heymans et al. (7, 8) reported that cardiac glycosides did not produce bradycardia in dogs when vagus nerves and also carotid sinus nerves were completely severed. The present author has also obtained a similar finding in cats using a cardiac glycoside, strospeside (9) .
In recent work of the present author (9), a hypothesis has been postulated on the mechanism of bradycardia produced by cardiac glycosides : There are two different kinds of nervous reflex systems, quite independent of each other, in producing brady cardia by cardiac glycosides. One is the vago-vagal reflex and the other is the carotid body-sympathetic nervous reflex chain possibly composed of the sinus nerve, cervical cord, stellate ganglion and the sympathetic fibers to the heart. The purpose of the present experiment is the presentation of some evidences for the possibility of the sympathetic portion of the hypothetical carotid body-sympathetic nervous chain, which is assumed to be the extravagal factor, by observing the effect of strospeside on the efferent discharges in the cardiac sympathetic nerves in cats.
METHODS
Cats were anesthetized with pentobarbital sodium (30 mg/kg i.v.) and bilateral vagus nerves were cut at the neck. During the experiments, further injections of pentobar bital were given as required, in order to prevent the appearance of jerks in response to sensory stimuli.
The drugs were injected into a cannula introduced into a femoral vein. Strospeside was dissolved in saline and fractional doses (single dose= 0.05 mg/kg) were injected intra venously at intervals of 5 minutes until death occurred. The heart rate was counted at one minute before every injection of strospeside.
Efferent discharges in the cardiac sympathetic nerves and electrocardiograms (standard limb lead II) were recorded simultaneously immediately before the injection of strospeside.
Recording method : In most of the experiments, the electrical activity in the efferent cardiac sympathetic fibers was recorded. The left stellate ganglion was exposed by making a resection of the second and third ribs under artificial respiration. In order to minimize artifacts, the upper lobe of the left lung was removed and the thorax was filled with paraffin oil. Electrical activity was recorded by placing the central ends of pre and postganglionic (cardiac branch) stellate fibers which had been cut distally across a pair of electrodes. The potentials picked up by the electrodes were amplified with a condensor-coupled amplifier (time constant =0.1 sec (10)) and displayed on a cathod-ray oscilloscope. The amplified action potentials and the electrocardiograms were recorded photographically. Heart rate was counted by means of electrocardiogram which had been fed into an audio-amplifier.
In such cases where respiratory artifacts were so prominent that the efferent dis charges were not constantly recorded, 1-3 mg/kg of Flaxedil (gallamine triethiodide) were injected at more than 20 minutes prior to the first injection of strospeside.
RESULTS
The results of the experiments were illustrated in Figs I. Efferent discharges in the left postganglionic stellate fibers (cardiac branch) a) Normal discharges One of the most striking characteristics of the efferent discharges in the postgang lionic stellate fibers was the grouping of the impulses at a frequency equal to that of the heart beats as already reported by Adrian (11), Bronk (12) and other investigators (10) . Respiratory grouping of the impulses was another remarkable feature, but some of the cats failed to show respiratory grouping.
The amplitude of the impulses was reduced temporarily immediately after 1-3 mg/kg of Flaxedil or 5-10 mg/kg of further injection of pentobarbital, but returned again to the normal level in less than 20 minutes and remained constant for one hour or more. Thus, the injection of strospeside was initiated 20 minutes after administration of Flaxedil or pentobarbital. The efferent discharges in the preganglionic stellate fibers showing grouped impulses at a frequency equal to that of the heart beats.
Bradycardia and inhibition of the efferent discharges in the preganglionic stellate fibers were produced by strospeside in doses of about 20--30% LD.
(a) : Changes in the heart rate. c) Effect of atropine on the action of strospeside An example of this experiment is shown in Fig. 2 . Atropine (0.1 mg/kg) was ad ministered intravenously prior to the injection of strospeside. In vagotomized cats, 0.1 mg/kg of atropine caused either a slight increase or no change in the heart rate. The efferent discharges in the postganglionic stellate fibers were not influenced by this dose of atropine.
JIG. 4. V agotomized cat.
The efferent impulses were continuously discharged in the preganglionic stellate fibers. No cardiac grouping of impulses was seen.
Bradycardia and inhibition of the efferent discharges in the preganglionic stellate fibers were produced by strospeside in doses of about 20-30% LD.
(a) : Changes in the heart rate. Strospeside injection was commenced 5 minutes after administration of atropine . Similar reduction of the efferent discharges with cardiac slowing was produced by increasing doses of strospeside also in atropinized cats as seen in non-atropinized animals.
From the data, it is evident that the inhibitory actions of strospeside on the heart rate and cardiac sympathetic impulses were not modified by 0.1 mg/kg of atropine.
II. Efferent discharges in the left preganglionic stellate fibers A question arose in the possible explanation of the reduction of the efferent dis charges in the postganglionic stellate fibers, because two possibilities were presented concerning the effect of strospeside upon the postganglionic impulses: An inhibition of the sympathetic center and a blocking (13) of the stellate ganglia.
To answer this question, the following experiments were conducted to study the effect of strospeside on discharges in the preganglionic stellate fibers. a) Normal discharges Two types of waves were noticed in the pattern of discharges of preganglionic stellate fibers : One was a type of high-amplitude discharges which showed grouped impulses at a frequency equal to that of the heart rate, and the other was a type of low-amplitude impulses discharged continuously without making any groupings. The amplitude of the efferent discharges was much smaller in the preganglionic stellate fibers than in the postganglionic stellate fibers. b) Effect of strospeside Three cases out of four showed similar reduction , of the efferent discharges in the preganglionic stellate fibers as in postganglionic fibers when 20-30% LD of strospeside were injected, and this inhibition of preganglionic impulses occurred also synchronously with cardiac slowing by strospeside. In one case, however, the preganglionic discharge was not so markedly reduced by strospeside as seen in the three cases.
The results obtained in the experiment with the cat which presented grouped im pulses of high-amplitude in preganglionic fibers were shown in Fig. 3 . This shows that strospeside inhibits sympathetic preganglionic discharges in the doses capable of producing cardiac slowing. Similar results were also observed in the cat presenting low-amplitude impulses which were continuously discharged in preganglionic fibers as seen in Fig. 4 .
DISCUSSION
The author (9) has already reported that strospeside produced a marked cardiac slowing in the cat unless its vagi and stellate ganglia were completely severed on both sides. Data obtained from the present experiment showed further information on the role of the sympathetic nerves played in the mechanism of bradycardia. If cardiac sympathetic nerves on one side were intact, strospeside produced bradycardia in vago tomized cats, even though the pre and postganglionic stellate fibers of the other side had been cut. This suggests that the cardiac sympathetic nerves of either side are capable of producing bradycardia. Thus, it is evident that a sympathetic factor parti cipates in producing bradycardia. Two possibilities were suggested for the explanation of the sympathetic mechanism of bradycardia : 1) Strospeside may increase the efferent activity of the cholinergic fibers which are possibly contained in the cardiac sympathetic nerves as pointed out by Burn and Rand (14) . 2) Strospeside may reduce the efferent activity of the adre nergic fibers which are contained in the cardiac sympathetic nerves.
As a matter of fact, atropine did not prevent bradycardia in the vagotomized animals and the efferent discharges in the postganglionic stellate fibers were markedly reduced synchronously with cardiac slowing by strospeside. It appears, therefore, that the first possibility is ruled out, and the fact that the efferent discharges in the preganglionic stellate fibers were also reduced synchronously with bradycardia makes the second pos sibility acceptable. In other words, the bradycardia by strospeside is partly due to the inhibition of the efferent activity in the adrenergic fibers.
The next point which arises is to determine the site of the inhibitory effect of strospeside on the efferent discharges in the cardiac sympathetic nerves. As shown in
Figs. 3 and 4, the efferent activity of the preganglionic stellate fibers was also inhibited by strospeside in doses capable of producing bradycardia without causing arrhythmia.
This fact suggests that the site of the inhibitory action of strospeside on the sympathetic discharges seems to be more central than the stellate ganglia, although the direct block ing action of strospeside on the stellate ganglia was not completely neglected. Konzett et al. (13) pointed out that large doses of cardiac glycosides block the sympathetic ganglia while small doses of cardiac glycosides potentiate the effect of preganglionic stimulation on the effector organ. The doses of cardiac glycosides necessary for the ganglionic blocking are much larger than doses which produce cardiac slowing. Accordingly, it is difficult to believe that the stellate ganglia are blocked by such small doses of stros peside as used in these experiments. As already reported (7-9), carotid sinus nerves were closely connected with the production of bradycardia by cardiac glycosides in vagotomized cats. Thus, it seems reasonable to conclude that strospeside reflectly inhibits the efferent discharges of pre and postganglionic sympathetic fibers and the inhibition of the discharges participates in producing bradycardia.
The evidence presented here also suggests that carotid sinus nerves and sympathetic nerves form a reflexogenic pathway which is considered to be one of the extravagal factors of bradycardia produced by strospeside.
SUMMARY
The effect of strospeside on the heart rate and the efferent discharges in the pre and postganglionic stellate fibers were studied using anesthetized cats.
1. Bradycardia and inhibition of the efferent discharges in the pre and postgang lionic stellate fibers were noticed synchronously when 20-30% LD of strospeside were administered.
2. Atropine (0.1 mg/kg) did not prevent the inhibitory actions of strospeside on the heart rate and on the efferent discharges in the postganglionic stellate fibers .
3. The mechanism of bradycardia due to strospeside was discussed with special reference to the sympathetic factor.
